Can clearing old cells help MS patients think and move better?
NCT ID NCT07270120
First seen Dec 08, 2025 · Last updated May 12, 2026 · Updated 20 times
Summary
This early-stage study tests whether a combination of two drugs, dasatinib and quercetin, can safely improve physical and mental function in adults aged 50-85 with secondary progressive multiple sclerosis (MS). Participants take the drugs every two weeks for three months. The goal is to see if removing aged, damaged cells can reduce inflammation and support nerve repair. The study involves 30 people and will track safety and any changes in symptoms over one year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS (MS) SECONDARY PROGRESSIVE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ohio State Martha Morehouse Outpatient Care
Columbus, Ohio, 43210, United States
Contact Phone: •••-•••-••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.